Find Valbenazine Tosylate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Valbenazine ditosylate, 1639208-54-0, Valbenazine tosilate, Valbenazine (tosylate), Nbi-98854 ditosylate, Valbenazine tosylate [usan]
Molecular Formula
C38H54N2O10S2
Molecular Weight
763.0  g/mol
InChI Key
BXGKAGLZHGYAMW-TZYFFPFWSA-N
FDA UNII
5SML1T733B

Valbenazine Tosylate
1 2D Structure

Valbenazine Tosylate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(2R,3R,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl] (2S)-2-amino-3-methylbutanoate;4-methylbenzenesulfonic acid
2.1.2 InChI
InChI=1S/C24H38N2O4.2C7H8O3S/c1-14(2)9-17-13-26-8-7-16-10-21(28-5)22(29-6)11-18(16)19(26)12-20(17)30-24(27)23(25)15(3)4;2*1-6-2-4-7(5-3-6)11(8,9)10/h10-11,14-15,17,19-20,23H,7-9,12-13,25H2,1-6H3;2*2-5H,1H3,(H,8,9,10)/t17-,19-,20-,23+;;/m1../s1
2.1.3 InChI Key
BXGKAGLZHGYAMW-TZYFFPFWSA-N
2.1.4 Canonical SMILES
CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1OC(=O)C(C(C)C)N)OC)OC
2.1.5 Isomeric SMILES
CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CC(C)C[C@@H]1CN2CCC3=CC(=C(C=C3[C@H]2C[C@H]1OC(=O)[C@H](C(C)C)N)OC)OC
2.2 Other Identifiers
2.2.1 UNII
5SML1T733B
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Valbenazine Ditosylate

2. 1639208-54-0

3. Valbenazine Tosilate

4. Valbenazine (tosylate)

5. Nbi-98854 Ditosylate

6. Valbenazine Tosylate [usan]

7. 5sml1t733b

8. 1639208-54-0 (tosylayte)

9. Valbenazine Tosilate (jan)

10. Valbenazine Tosylate (usan)

11. Valbenazine Tosilate [jan]

12. (2r,3r,11br)-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-yl L-valinate Di(4-methylbenzenesulfonate)

13. L-valine, (2r,3r,11br)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2h-benzo(a)quinolizin-2-yl Ester, 4-methylbenzenesulfonate (1:2)

14. Ingrezza (tn)

15. Nbi-98854 Tosylate

16. Unii-5sml1t733b

17. Valbenazine Tosylate (1:2)

18. Chembl3707248

19. Schembl18863051

20. Valbenazine Tosylate [mi]

21. Dtxsid201026308

22. Hy-16771a

23. S9500

24. Valbenazine Tosilate [who-dd]

25. Ccg-270445

26. Valbenazine Tosylate [orange Book]

27. Cs-0030913

28. D10999

29. Q27262815

30. (2r,3r,11br)-9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2h-benzo(a)quinolizin-2-yl L-valinate Bis(4-methylbenzenesulfonate)

31. [(2r,3r,11br)-9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1h-benzo[a]quinolizin-2-yl] (2s)-2-amino-3-methylbutanoate;4-methylbenzenesulfonic Acid

2.4 Create Date
2015-11-09
3 Chemical and Physical Properties
Molecular Weight 763.0 g/mol
Molecular Formula C38H54N2O10S2
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count12
Rotatable Bond Count10
Exact Mass762.32198827 g/mol
Monoisotopic Mass762.32198827 g/mol
Topological Polar Surface Area200 Ų
Heavy Atom Count52
Formal Charge0
Complexity776
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Drug and Medication Information
4.1 Drug Information
1 of 1  
Drug NameINGREZZA
Active IngredientVALBENAZINE TOSYLATE
CompanyNEUROCRINE (Application Number: N209241. Patents: 8039627, 8357697)

API SUPPLIERS

read-more
read-more

01

TAPI Technology & API Services

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
TAPI Company Banner

03

Crystal Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CAMX
Not Confirmed
arrow

Crystal Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
CAMX
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

Teva Pharmaceutical Industries

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CAMX
Not Confirmed
arrow

Teva Pharmaceutical Industries

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
CAMX
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

05

Lupin Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CAMX
Not Confirmed
arrow

Lupin Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
CAMX
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

06

Acharya Chemicals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CAMX
Not Confirmed
arrow

Acharya Chemicals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
CAMX
Not Confirmed
USDMF CEP/COS JDMF EU-WCInactive-api NDC KDMF VMF Others AUDIT
blank

07

Globe Quimica Ltda

Brazil

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CAMX
Not Confirmed
arrow

08

Viatris

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CAMX
Not Confirmed
arrow

Viatris

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
CAMX
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Farmhispania

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CAMX
Not Confirmed
arrow

10

Apotex Pharmachem

Canada

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CAMX
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

CAMX
Not Confirmed

01

CAMX
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2021-01-25

Pay. Date : 2021-01-11

DMF Number : 35195

Submission : 2020-12-05

Status : Active

Type : II

blank

02

CAMX
Not Confirmed

02

CAMX
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2020-11-30

Pay. Date : 2020-10-22

DMF Number : 35246

Submission : 2020-10-13

Status : Active

Type : II

blank

03

CAMX
Not Confirmed

04

CAMX
Not Confirmed

04

CAMX
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2021-02-02

Pay. Date : 2020-10-09

DMF Number : 35290

Submission : 2020-10-28

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1709058600,"product":"VALBENAZINE TOSYLATE","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LIFE SCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"EVEREST PAHRMACEUTICALS LTD","customerCountry":"BANGLADESH","quantity":"2.20","actualQuantity":"2.2","unit":"KGS","unitRateFc":"9000","totalValueFC":"19533.3","currency":"USD","unitRateINR":736704.54545454541,"date":"28-Feb-2024","totalValueINR":"1620750","totalValueInUsd":"19533.3","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"7901249","productDescription":"API","marketType":"","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722364200,"product":"VALBENAZINE TOSYLATE","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LIFE SCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"EVEREST PHARMACEUTICALS LTD","customerCountry":"BANGLADESH","quantity":"6.76","actualQuantity":"6.76","unit":"KGS","unitRateFc":"9000","totalValueFC":"60202.1","currency":"USD","unitRateINR":744432.24852071004,"date":"31-Jul-2024","totalValueINR":"5032362","totalValueInUsd":"60202.1","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"2859260","productDescription":"API","marketType":"","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1674412200,"product":"4001288 VALBENAZINE TOSYLATE","address":"12TH FLOOR, COMMERZ II,,INTERNATIO NAL BUSNESS PARK,OBEROI","city":"GARDEN CITY OFF WESTERN EXPR HIGHWA","supplier":"ASSIA CHEMICAL INDUSTRIES LTD","supplierCountry":"ISRAEL","foreign_port":"NA","customer":"WATSON PHARMA PRIVATE LTD","customerCountry":"INDIA","quantity":"25.50","actualQuantity":"25.5","unit":"KGS","unitRateFc":"3290","totalValueFC":"101339.6","currency":"USD","unitRateINR":"324920.4","date":"23-Jan-2023","totalValueINR":"8285470.2","totalValueInUsd":"101339.6","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"4320593","productDescription":"API","marketType":"","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"12TH FLOOR, COMMERZ II,,INTERNATIO NAL BUSNESS PARK,OBEROI"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1749234600,"product":"VALBENAZINE TOSYLATE VALBENAZINE TOSYLATE","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"MINDO PHARMA LTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"LUPIN LTD","customerCountry":"INDIA","quantity":"2.50","actualQuantity":"2.5","unit":"KGS","unitRateFc":"8920","totalValueFC":"22514","currency":"USD","unitRateINR":"773810","date":"07-Jun-2025","totalValueINR":"1934525","totalValueInUsd":"22514","indian_port":"Bombay Air","hs_no":"29349990","bill_no":"2516766","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"ROOM 226, NO.43 XINGNING ROAD, YINZ HOU DISTRICT, NINGBO Ningbo, , Chin a China","customerAddress":"159, C.S.T. ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1751567400,"product":"VALBENAZINE TOSYLATE VALBENAZINE TOSYLATE","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"MINDO PHARMA LTD","supplierCountry":"CHINA","foreign_port":"HONG KONG","customer":"LUPIN LTD","customerCountry":"INDIA","quantity":"1.90","actualQuantity":"1.9","unit":"KGS","unitRateFc":"8920","totalValueFC":"16974.4","currency":"USD","unitRateINR":"768904","date":"04-Jul-2025","totalValueINR":"1460917.6","totalValueInUsd":"16974.4","indian_port":"Bombay Air","hs_no":"29349990","bill_no":"3062596","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HONG KONG","supplierAddress":"ROOM 226, NO.43 XINGNING ROAD, YINZ HOU DISTRICT, NINGBO Ningbo, , Chin a China","customerAddress":"159, C.S.T. ROAD,"}]
23-Jan-2023
04-Jul-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more
  • Development Update

Details:

Valbenazine is a Other Small Molecule drug candidate, which is currently being evaluated in Phase II clinical studies for the treatment of Obsessive-Compulsive Disorder.


Lead Product(s): Valbenazine Tosylate,Inapplicable

Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Other Small Molecule

Sponsor: Neurocrine Biosciences

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 08, 2025

blank

01

University of Chicago

Country
arrow
CAMX
Not Confirmed

University of Chicago

Country
arrow
CAMX
Not Confirmed

Details : Valbenazine is a Other Small Molecule drug candidate, which is currently being evaluated in Phase II clinical studies for the treatment of Obsessive-Compulsive Disorder.

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

August 08, 2025

blank

Details:

Valbenazine is a Other Small Molecule drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Schizophrenia.


Lead Product(s): Valbenazine Tosylate,Inapplicable

Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Other Small Molecule

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 05, 2025

blank

02

CAMX
Not Confirmed
CAMX
Not Confirmed

Details : Valbenazine is a Other Small Molecule drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Schizophrenia.

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

August 05, 2025

blank

Details:

Ingrezza (valbenazine) is a selective vesicular monoamine transporter 2 (VMAT2) inhibitor approved by the U.S. FDA for the treatment adults with tardive dyskinesia.


Lead Product(s): Valbenazine Tosylate,Inapplicable

Therapeutic Area: Neurology Brand Name: Ingrezza

Study Phase: Phase IVProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 27, 2025

blank

03

CAMX
Not Confirmed
CAMX
Not Confirmed

Details : Ingrezza (valbenazine) is a selective vesicular monoamine transporter 2 (VMAT2) inhibitor approved by the U.S. FDA for the treatment adults with tardive dyskinesia.

Product Name : Ingrezza

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

February 27, 2025

blank
  • Development Update

Details:

Undisclosed


Lead Product(s): Valbenazine Tosylate,Inapplicable

Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Other Small Molecule

Sponsor: Neurocrine Biosciences

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 13, 2025

blank

04

Virginia Commonwealth University

Country
arrow
CAMX
Not Confirmed

Virginia Commonwealth University

Country
arrow
CAMX
Not Confirmed

Details : Undisclosed

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

January 13, 2025

blank

Details:

Valbenazine generic is a selective vesicular monoamine transporter 2 (VMAT2) inhibitor which is approved by the U.S. FDA for the treatment adults with tardive dyskinesia.


Lead Product(s): Valbenazine Tosylate,Inapplicable

Therapeutic Area: Neurology Brand Name: Ingrezza-Generic

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 08, 2024

blank

05

CAMX
Not Confirmed
CAMX
Not Confirmed

Details : Valbenazine generic is a selective vesicular monoamine transporter 2 (VMAT2) inhibitor which is approved by the U.S. FDA for the treatment adults with tardive dyskinesia.

Product Name : Ingrezza-Generic

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

September 08, 2024

blank

Details:

Ingrezza (valbenazine), a new sprinkle formulation of capsules, a selective VMAT2 inhibitor approved by USFDA for treating adults with tardive dyskinesia & chorea associated with Huntington's disease.


Lead Product(s): Valbenazine Tosylate,Inapplicable

Therapeutic Area: Genetic Disease Brand Name: Ingrezza

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 30, 2024

blank

06

CAMX
Not Confirmed
CAMX
Not Confirmed

Details : Ingrezza (valbenazine), a new sprinkle formulation of capsules, a selective VMAT2 inhibitor approved by USFDA for treating adults with tardive dyskinesia & chorea associated with Huntington's disease.

Product Name : Ingrezza

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

April 30, 2024

blank

07

CAMX
Not Confirmed
CAMX
Not Confirmed

Details : Undisclosed

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

March 15, 2024

blank

08

Stephen Ruedrich

Country
arrow
CAMX
Not Confirmed

Stephen Ruedrich

Country
arrow
CAMX
Not Confirmed

Details : Undisclosed

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

October 30, 2023

blank

Details:

Ingrezza (valbenazine) a new sprinkle formulation of capsules PDUFA target action date of April 30, 2024 and it is selective vesicular monoamine transporter 2 (VMAT2) inhibitor approved by the U.S. FDA for the treatment chorea associated with Huntington's disease (HD).


Lead Product(s): Valbenazine Tosylate,Inapplicable

Therapeutic Area: Neurology Brand Name: Ingrezza

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 14, 2023

blank

09

CAMX
Not Confirmed
CAMX
Not Confirmed

Details : Ingrezza (valbenazine) a new sprinkle formulation of capsules PDUFA target action date of April 30, 2024 and it is selective vesicular monoamine transporter 2 (VMAT2) inhibitor approved by the U.S. FDA for the treatment chorea associated with Huntington'...

Product Name : Ingrezza

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

September 14, 2023

blank

Details:

INGREZZA® (valbenazine) Capsules is the selective vesicular monoamine transporter 2 (VMAT2) inhibitor approved by the U.S. Food and Drug Administration for the treatment of adults with tardive dyskinesia and the treatment of chorea associated with Huntington's disease (HD).


Lead Product(s): Valbenazine Tosylate,Inapplicable

Therapeutic Area: Genetic Disease Brand Name: Ingrezza

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 18, 2023

blank

10

CAMX
Not Confirmed
CAMX
Not Confirmed

Details : INGREZZA® (valbenazine) Capsules is the selective vesicular monoamine transporter 2 (VMAT2) inhibitor approved by the U.S. Food and Drug Administration for the treatment of adults with tardive dyskinesia and the treatment of chorea associated with Hunti...

Product Name : Ingrezza

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

August 18, 2023

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 1639208-54-0 / Valbenazine Tosylate API manufacturers, exporters & distributors?

Valbenazine Tosylate manufacturers, exporters & distributors 1

99

PharmaCompass offers a list of Valbenazine Tosylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Valbenazine Tosylate manufacturer or Valbenazine Tosylate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Valbenazine Tosylate manufacturer or Valbenazine Tosylate supplier.

PharmaCompass also assists you with knowing the Valbenazine Tosylate API Price utilized in the formulation of products. Valbenazine Tosylate API Price is not always fixed or binding as the Valbenazine Tosylate Price is obtained through a variety of data sources. The Valbenazine Tosylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Valbenazine Tosylate

Synonyms

Valbenazine ditosylate, 1639208-54-0, Valbenazine tosilate, Valbenazine (tosylate), Nbi-98854 ditosylate, Valbenazine tosylate [usan]

Cas Number

1639208-54-0

Unique Ingredient Identifier (UNII)

5SML1T733B

Valbenazine Manufacturers

A Valbenazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Valbenazine, including repackagers and relabelers. The FDA regulates Valbenazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Valbenazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Valbenazine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Valbenazine Suppliers

A Valbenazine supplier is an individual or a company that provides Valbenazine active pharmaceutical ingredient (API) or Valbenazine finished formulations upon request. The Valbenazine suppliers may include Valbenazine API manufacturers, exporters, distributors and traders.

click here to find a list of Valbenazine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Valbenazine USDMF

A Valbenazine DMF (Drug Master File) is a document detailing the whole manufacturing process of Valbenazine active pharmaceutical ingredient (API) in detail. Different forms of Valbenazine DMFs exist exist since differing nations have different regulations, such as Valbenazine USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Valbenazine DMF submitted to regulatory agencies in the US is known as a USDMF. Valbenazine USDMF includes data on Valbenazine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Valbenazine USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Valbenazine suppliers with USDMF on PharmaCompass.

Valbenazine KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Valbenazine Drug Master File in Korea (Valbenazine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Valbenazine. The MFDS reviews the Valbenazine KDMF as part of the drug registration process and uses the information provided in the Valbenazine KDMF to evaluate the safety and efficacy of the drug.

After submitting a Valbenazine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Valbenazine API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Valbenazine suppliers with KDMF on PharmaCompass.

Valbenazine WC

A Valbenazine written confirmation (Valbenazine WC) is an official document issued by a regulatory agency to a Valbenazine manufacturer, verifying that the manufacturing facility of a Valbenazine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Valbenazine APIs or Valbenazine finished pharmaceutical products to another nation, regulatory agencies frequently require a Valbenazine WC (written confirmation) as part of the regulatory process.

click here to find a list of Valbenazine suppliers with Written Confirmation (WC) on PharmaCompass.

Valbenazine NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Valbenazine as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Valbenazine API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Valbenazine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Valbenazine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Valbenazine NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Valbenazine suppliers with NDC on PharmaCompass.

Valbenazine GMP

Valbenazine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Valbenazine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Valbenazine GMP manufacturer or Valbenazine GMP API supplier for your needs.

Valbenazine CoA

A Valbenazine CoA (Certificate of Analysis) is a formal document that attests to Valbenazine's compliance with Valbenazine specifications and serves as a tool for batch-level quality control.

Valbenazine CoA mostly includes findings from lab analyses of a specific batch. For each Valbenazine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Valbenazine may be tested according to a variety of international standards, such as European Pharmacopoeia (Valbenazine EP), Valbenazine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Valbenazine USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty